The current landscape of treatment for BPDCN

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=Mdqh_zcvP-c

Andrew Lane, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, gives an overview of the current landscape of treatment for patients with blastic plasmacytoi...

Speaker: Andrew Lane, Institution: Dana-Farber Cancer Institute, Event: ESH AL 2024, Format: Interview, Subject: Blastic Plasmacytoid Dendritic Cell Neoplasm, Subject: Rare Diseases, Subject: Acute Myeloid Leukemia, Subject: Leukemia, Field: Treatment, Field: Immuno-Oncology, Medicines: Tagraxofusp, Medicines: Venetoclax, Medicines: Antibodies, BPDCN, CD123-targeted, antibody-drug conjugate, Medicines: Pivekimab sunirine
#############################